Literature DB >> 17541395

A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

E De Braekeleer, N Douet-Guilbert, M-J Le Bris, C Berthou, F Morel, M De Braekeleer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17541395     DOI： 10.1038/sj.leu.2404773

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).

Authors:  Satu Mustjoki; Sari Hernesniemi; Auvo Rauhala; Marketta Kähkönen; Anders Almqvist; Tuija Lundán; Kimmo Porkka
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

2.  RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.

Authors:  Koiti Inokuchi; Satoshi Wakita; Tsuneaki Hirakawa; Hayato Tamai; Norio Yokose; Hiroki Yamaguchi; Kazuo Dan
Journal:  Int J Hematol       Date:  2011-08-24       Impact factor: 2.490

3.  Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Miriam Frech; Lutz B Jehn; Kathleen Stabla; Stephan Mielke; Björn Steffen; Hermann Einsele; Stephan K Metzelder; Andreas Neubauer
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

4.  Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Thomas Perwein; Sabine Strehl; Margit König; Herwig Lackner; Renate Panzer-Grümayer; Georg Mann; Andishe Attarbaschi; Ernst-Christian Urban; Oskar A Haas
Journal:  Haematologica       Date:  2016-04-28       Impact factor: 9.941

5.  Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.

Authors:  C Walz; N C P Cross; R A Van Etten; A Reiter
Journal:  Leukemia       Date:  2008-06-05       Impact factor: 11.528

Review 6.  Using bacterial artificial chromosomes in leukemia research: the experience at the university cytogenetics laboratory in Brest, France.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; Audrey Basinko; Frédéric Morel; Marie-Josée Le Bris; Claude Férec; Marc De Braekeleer
Journal:  J Biomed Biotechnol       Date:  2011-01-11

7.  The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues.

Authors:  Sandra Andersson; Kenneth Nilsson; Linn Fagerberg; Björn M Hallström; Christer Sundström; Angelika Danielsson; Karolina Edlund; Mathias Uhlen; Anna Asplund
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.

Authors:  Dongxue Wang; John R Horton; Yu Zheng; Robert M Blumenthal; Xing Zhang; Xiaodong Cheng
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

9.  RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Shawana Kamran; Gordana Raca; Kamran Nazir
Journal:  Case Rep Hematol       Date:  2015-10-27

10.  SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.

Authors:  Lauren M Brown; Soroor Hediyeh-Zadeh; Teresa Sadras; Hannah Huckstep; Jarrod J Sandow; Ray C Bartolo; Hansen J Kosasih; Nadia M Davidson; Breon Schmidt; Stefan Bjelosevic; Ricky Johnstone; Andrew I Webb; Seong L Khaw; Alicia Oshlack; Melissa J Davis; Paul G Ekert
Journal:  Blood Adv       Date:  2022-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.